Investing.com - Neuronetics (NASDAQ: STIM) reported first quarter EPS of $-0.19, $0.07 better than the analyst estimate of $-0.26. Revenue for the quarter came in at $20.3M versus the consensus estimate of $19.85M.
Guidance
Neuronetics sees Q1 2024 revenue of $16.70M-$17.70M versus the analyst consensus of $16.98M.
Neuronetics sees FY 2024 revenue of $78.00M-$80.00M versus the analyst consensus of $78.64M.
Neuronetics's stock price closed at $2.79. It is up 52.46% in the last 3 months and down -46.45% in the last 12 months.
Neuronetics saw 2 positive EPS revisions and 1 negative EPS revisions in the last 90 days. See Neuronetics's stock price’s past reactions to earnings here.
According to InvestingPro, Neuronetics's Financial Health score is "fair performance".
Check out Neuronetics's recent earnings performance, and Neuronetics's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar